We’re hearing more and more about precision medicine and how it can positively impact medicine. But what is preventing it from reaching its full potential, and how can everyone from hospitals to startups help scale it?
This question will be up for discussion at the MedCity CONVERGE conference in Philadelphia on July 11-12.
Prior to the event, Andrew Norden, chief medical officer of oncology-focused startup Cota and a panelist on the “How to Scale Precision Medicine” panel, discussed setbacks and opportunities for the field.
